SwePub
Sök i LIBRIS databas

  Extended search

hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska och farmaceutiska grundvetenskaper) hsv:(Neurovetenskaper)
 

Search: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska och farmaceutiska grundvetenskaper) hsv:(Neurovetenskaper) > Advances in kinase ...

  • Rask-Andersen, MathiasUppsala universitet,Funktionell farmakologi (author)

Advances in kinase targeting : current clinical use and clinical trials

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • Elsevier BV,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-97591
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-97591URI
  • https://doi.org/10.1016/j.tips.2014.09.007DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-238746URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:for swepub-publicationtype

Notes

  • Phosphotransferases, also known as kinases, are the most intensively studied protein drug target category in current pharmacological research, as evidenced by the vast number of kinase-targeting agents enrolled in active clinical trials. This development has emerged following the great success of small-molecule, orally available protein kinase inhibitors for the treatment of cancer, starting with the introduction of imatinib (Gleevec (R)) in 2003. The pharmacological utility of kinase-targeting has expanded to include treatment of inflammatory diseases, and rapid development is ongoing for kinase-targeted therapies in a broad array of indications in ophthalmology, analgesia, central nervous system (CNS) disorders, and the complications of diabetes, osteoporosis, and otology. In this review we highlight specifically the kinase drug targets and kinase-targeting agents being explored in current clinical trials. This analysis is based on a recent estimate of all established and clinical trial drug mechanisms of action, utilizing private and public databases to create an extensive dataset detailing aspects of more than 3000 approved and experimental drugs.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Zhang, JinUppsala universitet,Umeå universitet,Kemiska institutionen,Funktionell farmakologi(Swepub:uu)jinzh961 (author)
  • Fabbro, Doriano (author)
  • Schiöth, Helgi BUppsala universitet,Funktionell farmakologi(Swepub:uu)helgschi (author)
  • Uppsala universitetFunktionell farmakologi (creator_code:org_t)

Related titles

  • In:TIPS - Trends in Pharmacological Sciences: Elsevier BV35:11, s. 60-760165-61471873-3735

Internet link

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Rask-Andersen, M ...
Zhang, Jin
Fabbro, Doriano
Schiöth, Helgi B
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmaceutical S ...
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Medicinal Chemis ...
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Neurosciences
Articles in the publication
TIPS - Trends in ...
By the university
Umeå University
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view